Clinical Trial Update: Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intravesical mitomycin C with Bacillus Calmette-Guerin for non-muscle-invasive bladder cancer was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guerin (Bacillus Calmette-Guerin)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Bladder Cancer | Phase 3 | Status: TERMINATED | Results posted: 2015-11-20